PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 6 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Schonfeld Group Holdings LLC | 15,000 | $12,000 | 0.09% |
| Cutter & CO Brokerage, Inc. | 94,500 | $77,000 | 0.03% |
| PRINCETON CAPITAL MANAGEMENT LLC | 25,000 | $20,000 | 0.02% |
| STANCORP INVESTMENT ADVISERS INC | 14,000 | $11,000 | 0.01% |
| WADE G W & INC | 30,000 | $24,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 18,000 | $15,000 | 0.00% |
| Estate Counselors, LLC | 10,000 | $8,000 | 0.00% |
| LUPO SECURITIES, LLC | 800 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 122,755 | $100,000 | 0.00% |
| Commonwealth Equity Services, Inc | 80,500 | $66,000 | 0.00% |